Different	O
microRNA	B:C2825314
alterations	O
contribute	O
to	O
diverse	O
outcomes	O
following	O
Enterovirus	B:C3853962
71	I:C3853962
and	O
CA16	O
infections	B:C3714514
:	O
Insights	O
from	O
high	B:C2936623
-	I:C2936623
throughput	I:C2936623
sequencing	I:C2936623
in	O
rhesus	B:C0024400
monkey	I:C0024400
peripheral	B:C1321301
blood	I:C1321301
mononuclear	I:C1321301
cells	I:C1321301
.	O

Enterovirus	B:C2963492
71	I:C2963492
(	O
Enterovirus	B:C2963492
71	I:C2963492
)	O
and	O
Coxsackievirus	O
A16	O
(	O
CA16	O
)	O
are	O
the	O
predominant	O
pathogens	O
of	O
hand	B:C0018572
,	I:C0018572
foot	I:C0018572
,	I:C0018572
and	I:C0018572
mouth	I:C0018572
disease	I:C0018572
(	O
hand	B:C0018572
,	I:C0018572
foot	I:C0018572
,	I:C0018572
and	I:C0018572
mouth	I:C0018572
disease	I:C0018572
)	O
.	O

Although	O
these	O
viruses	B:C0042776
exhibit	O
genetic	B:C0314643
homology	I:C0314643
,	O
the	O
clinical	O
manifestations	O
caused	O
by	O
the	O
two	O
viruses	B:C0042776
have	O
some	O
discrepancies	B:C1290905
.	O

microRNAs	B:C1101610
(	O
microRNAs	B:C1101610
)	O
participate	O
in	O
numerous	O
biological	B:C3714634
or	O
pathological	B:C0030660
processes	I:C0030660
,	O
including	O
host	B:C0301872
responses	I:C0301872
to	O
viral	B:C0042769
infections	I:C0042769
.	O

Here	O
,	O
we	O
focused	O
on	O
differences	O
in	O
miRNA	B:C2825314
expression	B:C0017262
patterns	B:C0449774
in	O
rhesus	B:C0024400
monkey	I:C0024400
peripheral	B:C1321301
blood	I:C1321301
mononuclear	I:C1321301
cells	I:C1321301
(	O
peripheral	B:C1321301
blood	I:C1321301
mononuclear	I:C1321301
cells	I:C1321301
)	O
infected	B:C0439663
with	O
Enterovirus	B:C2963492
71	I:C2963492
and	O
CA16	O
at	O
various	O
time	O
points	O
using	O
high	B:C2936623
-	I:C2936623
throughput	I:C2936623
sequencing	I:C2936623
.	O

The	O
results	O
demonstrated	O
that	O
106	O
known	O
and	O
13	O
novel	O
microRNAs	B:C1101610
exhibited	O
significant	O
differences	O
,	O
and	O
32	O
key	O
microRNAs	B:C1101610
among	O
them	O
for	O
target	O
prediction	O
presented	O
opposite	O
trends	O
in	O
the	O
Enterovirus	B:C3853962
71	I:C3853962
-	O
and	O
CA16	O
-	O
infected	B:C0439663
samples	O
.	O

GO	B:C1138831
and	O
pathway	B:C0868995
analysis	I:C0868995
of	O
the	O
predicted	O
targets	O
showed	O
enrichment	O
in	O
14	O
biological	B:C3714634
processes	I:C3714634
,	O
10	O
molecular	B:C1148560
functions	I:C1148560
,	O
8	O
cellular	B:C1166607
components	I:C1166607
and	O
104	O
pathways	O
.	O

Subsequently	O
,	O
regulatory	B:C1720950
networks	I:C1720950
of	O
miRNA	B:C1101610
-	O
transcription	B:C0040648
factors	I:C0040648
,	O
miRNA	B:C1101610
-	O
predicted	O
targets	O
,	O
miRNA	B:C1101610
-	O
GOs	B:C1138831
and	O
miRNA	B:C1101610
-	O
pathways	O
were	O
constructed	O
to	O
reveal	O
the	O
complex	O
regulatory	O
mechanisms	O
of	O
microRNAs	B:C1101610
during	O
the	O
infection	B:C1321909
phase	I:C1321909
.	O

Ultimately	O
,	O
we	O
analysed	B:C0936012
hierarchical	O
GO	B:C1138831
categories	B:C0683312
of	O
the	O
predicted	O
targets	O
involved	O
in	O
immune	B:C1817756
system	I:C1817756
processes	I:C1817756
,	O
which	O
indicated	O
that	O
the	O
innate	O
and	O
adaptive	B:C0678209
immunity	I:C0678209
following	O
Enterovirus	B:C3853962
71	I:C3853962
and	O
CA16	O
infections	B:C3714514
may	O
be	O
remarkably	O
distinct	O
.	O

In	O
conclusion	O
,	O
this	O
report	B:C0684224
is	O
the	O
first	O
describing	O
miRNA	B:C2825314
expression	O
profiles	O
in	O
peripheral	B:C1321301
blood	I:C1321301
mononuclear	I:C1321301
cells	I:C1321301
with	O
Enterovirus	B:C3853962
71	I:C3853962
and	O
CA16	O
infections	B:C3714514
using	O
high	B:C2936623
-	I:C2936623
throughput	I:C2936623
sequencing	I:C2936623
.	O

Our	O
findings	O
could	O
provide	O
a	O
valuable	O
basis	O
for	O
further	O
studies	B:C2603343
on	O
the	O
regulatory	O
roles	O
of	O
microRNAs	B:C1101610
related	O
to	O
the	O
different	O
immune	B:C0301872
responses	I:C0301872
caused	O
by	O
Enterovirus	B:C3853962
71	I:C3853962
and	O
CA16	O
infections	B:C3714514
.	O

